Don’t Stop Here

More To Explore

NMRA: Workforce Cuts Follow Failed Depression Trials

Company Overview Neumora Therapeutics (NASDAQ: NMRA) is a clinical-stage biopharmaceutical company focused on neuroscience, recently thrust into the spotlight after a major late-stage trial setback.